Distribution of Bacteria in OME After Radiotherapy For NPC. (NCT06523933) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Distribution of Bacteria in OME After Radiotherapy For NPC.
China234 participantsStarted 2024-05-12
Plain-language summary
To observe the prognostic difference of tympanocentesis in different kinds of otitis media effusion.
Who can participate
Age range15 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patients clinical diagnosis of OME or OME after radiotherapy for NPC (Diagnostic criteria: fluid visible in the middle ear and a type B tympanogram).
* patients volunteered to participate in the study and signed the informed consent
Exclusion Criteria:
* NPC recurrence or other malignant tumor after radiotherapy.
* clear diagnosis of Eustachian ostium atresia or nasal obstruction diseases, such as severe deviated nasal septum, choanal atresia, osteoradionecrosis of skull base after radiotherapy, etc.
* pregnant and lactating women.
* patients with severe underlying diseases or with severe liver and kidney dysfunction.
* patients who could not cooperate (including poor hearing and radiation encephalopathy)
* patients with other middle ear diseases, such as middle ear cholesteatoma, osteoradionecrosis of temporal bone after radiotherapy, etc.
* severe deglutition disorders
* cleft palate
What they're measuring
1
Positive Bacterial Culture Rate in Middle Ear Effusion
Timeframe: Up to 24 weeks
Trial details
NCT IDNCT06523933
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University